Abstract
(Englisch)
|
Mylife diabetes care and ETH will develop a digital-twin insulin-infusion technology to optimize insulin delivery and extend infusion-set wear time, improving absorption and biocompatibility. This will reduce the burden on patients, improving both their overall benefit and clinical outcomes.
|
